Trulieve schedules November 5 results as stock trades at EUR 9.63
Published on 10/27/2026 at 13:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSDates and balance sheet
- Trulieve repaid USD 65 million of mortgage notes on October 7, 2026.
- Second-quarter revenue reached USD 271 million at a 60 percent gross margin.
- Trulieve Cannabis stock was trading at EUR 9.63 at 1:42 p.m. CET at Lang & Schwarz on October 27, 2026.
- Cantor Fitzgerald kept its USD 15.00 target on October 23, 2026.
Trulieve Cannabis (ISIN US89790E1064) is scheduled to release third-quarter results on November 5, 2026, while its stock was trading at EUR 9.63 at Lang & Schwarz on October 27, 2026. The upcoming report follows second-quarter revenue of USD 271 million and a 60 percent gross margin, according to Benzinga.
November 5 is the next marker
Trulieve said on October 6, 2026, that it would publish third-quarter results on November 5, 2026, followed by an 8:30 a.m. ET conference call. Management expects third-quarter revenue from the medical-only business to be comparable with the USD 222 million reported for that business in the second quarter, as Georgia and Pennsylvania growth offsets seasonal pressure in Florida.
The quarterly comparison matters because the second quarter included the Harvest business until the June 3 deconsolidation and medical-only operations afterward. Adjusted EBITDA reached USD 98 million, equal to a 36 percent margin, while operating cash flow was USD 53 million in the second quarter, Benzinga reported.
What changed during October
Trulieve's recent sequence shows a shift from expansion to balance-sheet execution. On September 28, 2026, the company announced exclusive Connected licensing rights covering Florida and Texas, as reported by PR Newswire.
On October 7, 2026, Trulieve repaid USD 65 million of mortgage notes secured by a Florida cultivation site, reducing outstanding debt to USD 225 million, MMJDaily reported. The repayment was made before maturity and was intended to lower interest expense while preserving funding for Georgia and Texas expansion.
On October 23, 2026, Cantor Fitzgerald maintained its Overweight rating and USD 15.00 price target after a Florida site visit, according to Investing.com. The target is a separate valuation reference from the euro quotation and does not change the trading snapshot.
Three dates define the setup
The September 28, 2026 licensing agreement, the October 7, 2026 USD 65 million repayment and the October 23, 2026 USD 15.00 target form the recent chronology. The next dated event is the November 5, 2026 third-quarter results release and conference call.
Stock price and investor context
For investors, the November report will show the first full quarter after the Harvest deconsolidation and will test whether medical-only revenue can hold the USD 222 million second-quarter base. The balance sheet also enters the report with USD 225 million of debt after the mortgage repayment.
The stock was trading at EUR 9.63 at Lang & Schwarz on October 27, 2026 at 1:42 p.m. CET.
The further course of trading is shown by the continuously updated real-time quote of Trulieve Cannabis stock.
Trulieve Cannabis stock facts
- Company: Trulieve Cannabis Corp.
- ISIN: US89790E1064
- Ticker: TRUL
- Primary exchange: Canadian Securities Exchange
- Price Lang & Schwarz (as of October 27, 2026, 1:42 p.m. CET): EUR 9.63
- Sector / Industry: Cannabis / medical cannabis operator
Market context: Latest market reports.
